Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial

B Bonanni, M Puntoni, M Cazzaniga… - Journal of clinical …, 2012 - ascopubs.org
Purpose Metformin is associated with reduced breast cancer risk in observational studies in
patients with diabetes, but clinical evidence for antitumor activity is unclear. The change in Ki …

Digital pathology and image analysis in tissue biomarker research

PW Hamilton, P Bankhead, Y Wang, R Hutchinson… - Methods, 2014 - Elsevier
Digital pathology and the adoption of image analysis have grown rapidly in the last few
years. This is largely due to the implementation of whole slide scanning, advances in …

Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery

DG Booth, M Takagi, L Sanchez-Pulido, E Petfalski… - Elife, 2014 - elifesciences.org
When the nucleolus disassembles during open mitosis, many nucleolar proteins and RNAs
associate with chromosomes, establishing a perichromosomal compartment coating the …

Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

O Bjarnadottir, Q Romero, PO Bendahl… - Breast cancer research …, 2013 - Springer
Lipophilic statins purportedly exert anti-tumoral effects on breast cancer by decreasing
proliferation and increasing apoptosis. HMG-CoA reductase (HMGCR), the rate-limiting …

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

S Niraula, RJO Dowling, M Ennis, MC Chang… - Breast cancer research …, 2012 - Springer
Metformin may exert anti-cancer effects through indirect (insulin-mediated) or direct (insulin-
independent) mechanisms. We report results of a neoadjuvant “window of opportunity” study …

[HTML][HTML] Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice

G Pelosi, G Rindi, WD Travis, M Papotti - Journal of thoracic oncology, 2014 - Elsevier
Classification of lung neuroendocrine (NE) tumors is a step-wise process with four tumor
categories being identified by morphology, namely typical carcinoid (TC), atypical carcinoid …

[HTML][HTML] Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario. Octava revisión. Colima 2019

J Cárdenas-Sánchez, AAE Valle-Solís… - Gaceta mexicana de …, 2019 - scielo.org.mx
El cáncer de mama es la neoplasia más común en mujeres a nivel mundial, al igual que en
nuestro país. Sin embargo, en México, existen diferencias que son importantes de identificar …

Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1-98 trial

O Metzger Filho, A Giobbie-Hurder, E Mallon… - Journal of Clinical …, 2015 - ascopubs.org
Purpose To evaluate the relative effectiveness of letrozole compared with tamoxifen for
patients with invasive ductal or lobular carcinoma. Patients and Methods Patients diagnosed …

Biomarkers for the clinical management of breast cancer: international perspective

N Patani, LA Martin, M Dowsett - International journal of cancer, 2013 - Wiley Online Library
The higher incidence of breast cancer in developed countries has been tempered by
reductions in mortality, largely attributable to mammographic screening programmes and …

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast-and Gynecopathologists

Z Varga, J Diebold, C Dommann-Scherrer, H Frick… - PloS one, 2012 - journals.plos.org
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the
pathologist's assessment of tumor proliferation. The Swiss Working Group of Gyneco-and …